World AIDS Day
Follow @HRSAgov and join their Twitter thread from November 29-December 2 using #HRSAHonorsWAD and Register for the 12/1 HRSA WAD Commemoration Event
Event updated 01/18/2024
Follow @HRSAgov and join their Twitter thread from November 29-December 2 using #HRSAHonorsWAD and Register for the 12/1 HRSA WAD Commemoration Event
Event updated 01/18/2024
Resource updated 08/28/2023
Blog updated 01/07/2021
Tool used by planners to facilitate plan implementation by use of an outline of recommended changes and status updates as a way to break down larger activities and track progress.
Resource updated 09/19/2023
In response to clinic operation curtailments during COVID-19 lockdowns, telehealth services have expanded across the nation.
Blog updated 01/17/2023
Review of the Training of Consumers for Quality Plus Program (TCQPlus), which prepares a team of training partners (staff and consumers to conduct quality improvement trainings.
Resource updated 03/14/2023
Blog updated 02/01/2021
Resource updated 03/15/2023
Resource updated 02/02/2021
Resource updated 02/27/2024
Rapid has developed into a core feature of the Dorothy Mann Center HIV care continuum, assuring immediate linkage to expert HIV services, immediate initiation of therapy, and rapid viral suppression. Benefits are present for youth prevention services. Rapid access models are feasible and beneficial for youth HIV care and prevention.
Resource (Conference Presentation) updated 09/14/2023
A clinic-based substance abuse screening and treatment program is described. Using the Screening, Brief Intervention, and Referral to Treatment model, this provides annual proactive screening of alcohol/drug use, with a brief provider response and a follow-up motivational interviewing brief intervention, with treatment provided by an embedded provider.
Resource (Conference Presentation) updated 09/14/2023
Oklahoma has been classified by the Department of Health and Human Services as one of the seven states with a high rural HIV burden. Test-and-treat protocols are feasible within high-volume HIV clinics which serve rural and underserved communities to minimize the time to the first appointment to decrease time to viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
This interactive workshop will share Virginia's experiences and lessons learned from the Virginia Consumer Advisory Committee (VACAC). The workshop will provide perspective on effectively engaging consumers in ending the HIV/AIDS epidemic. The session will highlight VACAC's structure and how it interacts with consumers, the Virginia Department of Health, and service providers.
Resource (Conference Presentation) updated 09/14/2023
This session will explore the continuum of meaningful involvement among persons with HIV at the community, regional, and national levels. A panel of community stakeholders will share experiences participating in community forums, boards, and other advocacy opportunities.
Resource (Conference Presentation) updated 09/14/2023
Cuaderno de trabajo sobre cómo establecer y operar una junta asesora para los consumidores (CAB, siglas en inglés), relacionada con las operaciones de CAB para los programas dirigidos a las mujeres, bebés, niños y jóvenes de la Parte D (Título IV).
Resource updated 09/19/2023
This workshop will help participants assess and improve their collaborative process with Integrated HIV Prevention and Care Plan development and implementation. Presenters will describe challenges and facilitators with cross-Part collaboration on integrated planning, including the development, implementation, monitoring and improvement of integrated plans, and alignment with other planning efforts.
Resource (Conference Presentation) updated 09/14/2023
This session will describe the five optimal stages of integrated planning and introduce lessons learned, best practices, and resources for the cyclical integrated planning process and development of the Integrated HIV Prevention and Care Plans.
Resource (Conference Presentation) updated 09/14/2023
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approval of these drugs. There will be a brief overview of the ATLAS and FLAIR studies, discussion of the medications, and an outline of the potential impact of the regimens on care delivery models, providers, patients, and payers if they are approved.
Resource (Conference Presentation) updated 09/14/2023